5-fluoropyridine-2-carbonitrile;4-(trifluoromethyl)phenol;5-[4-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile
C26H15F7N4O2 — CID 158076502
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-fluoropyridine-2-carbonitrile;4-(trifluoromethyl)phenol;5-[4-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile
5-fluoropyridine-2-carbonitrile;4-(trifluoromethyl)phenol;5-[4-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile (PubChem CID 158076502) has the molecular formula C26H15F7N4O2 and a molecular weight of 548.42 g/mol. Its IUPAC name is 5-fluoropyridine-2-carbonitrile;4-(trifluoromethyl)phenol;5-[4-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile.
Molecular Properties
| Compound Name | 5-fluoropyridine-2-carbonitrile;4-(trifluoromethyl)phenol;5-[4-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile |
|---|---|
| PubChem CID | 158076502 |
| Molecular Formula | C26H15F7N4O2 |
| Molecular Weight | 548.42 g/mol |
| Exact Mass | 548.11 |
| IUPAC Name | 5-fluoropyridine-2-carbonitrile;4-(trifluoromethyl)phenol;5-[4-(trifluoromethyl)phenoxy]pyridine-2-carbonitrile |
| SMILES | N#Cc1ccc(F)cn1.N#Cc1ccc(Oc2ccc(C(F)(F)F)cc2)cn1.Oc1ccc(C(F)(F)F)cc1 |
| InChI | InChI=1S/C13H7F3N2O.C7H5F3O.C6H3FN2/c14-13(15,16)9-1-4-11(5-2-9)19-12-6-3-10(7-17)18-8-12;8-7(9,10)5-1-3-6(11)4-2-5;7-5-1-2-6(3-8)9-4-5/h1-6,8H;1-4,11H;1-2,4H |
| InChIKey | FMKZHEUERXSWJA-UHFFFAOYSA-N |
| XLogP | 7.27 |
| TPSA | 102.82 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 6 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 548.42 |
| LogP ≤ 5 | 7.27 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 6 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158076502 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.